| Michael J Lannon, MD | |
|
19 Hampton Rd, Exeter, NH 03833-4838 | |
| (603) 778-1752 | |
| (603) 772-1493 |
| Full Name | Michael J Lannon |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 19 Hampton Rd, Exeter, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386602522 | NPI | - | NPPES |
| 82084214 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5637 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Lannon, MD Po Box 655, Exeter, NH 03833-0655 Ph: (603) 778-1752 | Michael J Lannon, MD 19 Hampton Rd, Exeter, NH 03833-4838 Ph: (603) 778-1752 |
News Archive
The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.
The creation of a silica nanocapsule could allow treatments that use light to destroy cancerous or precancerous cells in the skin to also be used to treat other types of cancer.
› Verified 1 days ago
Kristin Vaughan, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Hampton Rd, Exeter, NH 03833 Phone: 603-775-0000 Fax: 603-775-0247 | |
Andrew S Weeks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Alumni Dr Fl 2, Exeter, NH 03833 Phone: 603-580-7525 Fax: 603-580-7542 | |
Susan D Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Alumni Dr, Exeter, NH 03833 Phone: 603-772-2981 Fax: 603-772-0931 | |
Dr. James Arthur Bloomer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 21 Hampton Rd, Building 2, Suite 201, Exeter, NH 03833 Phone: 603-418-6310 Fax: 603-418-6311 | |
Michael A Pangan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Hampton Rd Bldg 2, Exeter, NH 03833 Phone: 603-775-0000 Fax: 603-658-0032 | |
Joellen Thomas, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9 Buzell Ave, Exeter, NH 03833 Phone: 603-773-5200 Fax: 603-773-5233 | |
Dr. Michael C Wu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Hampton Rd Bldg 3, Exeter, NH 03833 Phone: 603-775-0000 Fax: 603-778-2491 |